| 肌无力危象的治疗研究进展 |
| |
| 引用本文： | 马艳艳,刘建军.肌无力危象的治疗研究进展[J].医学信息,2019,0(6):45-47. |
| |
| 作者姓名： | 马艳艳 刘建军 |
| |
| 作者单位： | （西安医学院附属西安高新医院神经内科，陕西 西安 710075） |
| |
| 摘 要： | 重症肌无力是发生在神经肌肉接头处、由抗体介导、细胞免疫依赖、补体参与的自身免疫性疾病，死亡率较高。肌无力危象的急救处理包括胆碱酯酶抑制剂、糖皮质激素、免疫抑制剂、静脉注射人免疫球蛋白、血浆置换、胸腺切除、机械通气等。近年来，随着国内外医疗水平的提高及免疫学研究的不断进展，对肌无力危象的治疗有了更深入的认识，其病死率呈逐渐下降趋势，使该病治愈成为可能。本文就近些年来对肌无力危象的治疗进行综述，为临床治疗提供参考。
|
| 关 键 词： | 重症肌无力 肌无力危象 糖皮质激素 免疫抑制剂 |
Progress in the Treatment of Myasthenia Crisis |
| |
| MA Yan-yan,LIU Jian-jun.Progress in the Treatment of Myasthenia Crisis[J].Medical Information,2019,0(6):45-47. |
| |
| Authors: | MA Yan-yan LIU Jian-jun |
| |
| Affiliation: | (Department of Neurology,Xi'an High-tech Hospital affiliated to Xi'an Medical College,Xi'an 710075,Shaanxi,China) |
| |
| Abstract: | Myasthenia gravis is an autoimmune disease that occurs at the neuromuscular junction, is mediated by antibodies, cellular immune dependence, and complement, and has a high mortality rate. Emergency treatment of myasthenia gravis includes cholinesterase inhibitors, glucocorticoids, immunosuppressants, intravenous human immunoglobulins, plasma exchange, thymectomy, mechanical ventilation, and the like. In recent years, with the improvement of medical standards at home and abroad and the continuous advancement of immunology research, the treatment of myasthenia gravis has gained a deeper understanding, and the mortality rate has gradually declined, making it possible to cure the disease. This article reviews the treatment of myasthenia gravis in recent years and provides a reference for clinical treatment. |
| |
| Keywords: | Myasthenia gravis Myasthenia crisis Glucocorticoid Immunosuppressive agent |
|
| 点击此处可从《医学信息》浏览原始摘要信息 |
|
点击此处可从《医学信息》下载全文 |
|
